Santori & Peters Inc’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,964
| Closed | -$213K | – | 50 |
|
|
2022
Q4 | $213K | Sell |
2,964
-70
| -2% | -$5.04K | 0.13% | 46 |
|
|
2022
Q3 | $215K | Buy |
3,034
+287
| +10% | +$20.3K | 0.14% | 42 |
|
|
2022
Q2 | $211K | Buy |
+2,747
| New | +$211K | 0.14% | 47 |
|
|
2022
Q1 | – | Sell |
-5,627
| Closed | -$350K | – | 56 |
|
|
2021
Q4 | $350K | Buy |
5,627
+36
| +0.6% | +$2.24K | 0.18% | 39 |
|
|
2021
Q3 | $330K | Buy |
5,591
+31
| +0.6% | +$1.83K | 0.19% | 40 |
|
|
2021
Q2 | $371K | Buy |
5,560
+32
| +0.6% | +$2.14K | 0.21% | 39 |
|
|
2021
Q1 | $348K | Sell |
5,528
-7,130
| -56% | -$449K | 0.21% | 41 |
|
|
2020
Q4 | $791K | Buy |
12,658
+63
| +0.5% | +$3.94K | 0.44% | 26 |
|
|
2020
Q3 | $759K | Buy |
12,595
+7,195
| +133% | +$434K | 0.5% | 26 |
|
|
2020
Q2 | $317K | Sell |
5,400
-6,922
| -56% | -$406K | 0.24% | 41 |
|
|
2020
Q1 | $686K | Buy |
12,322
+29
| +0.2% | +$1.62K | 0.59% | 20 |
|
|
2019
Q4 | $789K | Buy |
12,293
+2,776
| +29% | +$178K | 0.52% | 27 |
|
|
2019
Q3 | $482K | Buy |
9,517
+124
| +1% | +$6.28K | 0.35% | 36 |
|
|
2019
Q2 | $426K | Buy |
+9,393
| New | +$426K | 0.31% | 42 |
|
|
2019
Q1 | – | Sell |
-9,326
| Closed | -$484K | – | 54 |
|
|
2018
Q4 | $484K | Buy |
+9,326
| New | +$484K | 0.43% | 31 |
|
|
2018
Q1 | – | Sell |
-2,308
| Closed | -$144K | – | 116 |
|
|
2017
Q4 | $144K | Buy |
+2,308
| New | +$144K | 0.13% | 59 |
|